• LAST PRICE
    0.0196
  • TODAY'S CHANGE (%)
    Trending Up0.0001 (0.5128%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0198 / 0.0195
  • Day Range
    Low 0.0186
    High 0.0200
  • 52 Week Range
    Low 0.0120
    High 0.1090
  • Volume
    1,721,537
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.0195
TimeVolumeHALB
09:32 ET60000.01975
09:35 ET100000.0199
09:42 ET350000.0199
09:44 ET180000.0199
09:48 ET10000.0195
09:57 ET2000.0199
10:11 ET7000.0193
10:13 ET1000000.0192
10:15 ET300000.0191
10:18 ET700000.019
10:20 ET2701630.01864
10:27 ET800000.019
10:33 ET1271600.019
11:23 ET250000.01914
11:25 ET150000.0191
11:45 ET1000000.0199
12:39 ET50000.0195
12:42 ET1000.0195
12:57 ET80000.0199
01:11 ET200000.0195
01:27 ET850000.0191
01:40 ET1728400.0191
02:05 ET60000.01924
02:07 ET1609880.0191
02:43 ET200000.0191
02:45 ET640120.0191
02:56 ET180000.0192
03:15 ET14110.0195
03:17 ET796930.019705
03:21 ET25000.0196
03:39 ET867350.0196
03:46 ET630000.0197
03:57 ET400000.0196
Data delayed at least 15 minutes.

Jan 13, 2022

Jan 5, 2022

8:01AM ET on Wednesday Jan 05, 2022 by Accesswire

8:01AM ET on Wednesday Jan 05, 2022 by Newsfile
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesHALB
Halberd Corp
10.0M
8.4x
---
United StatesSNES
Senestech Inc
11.0M
-0.9x
---
United StatesMHTX
Manhattan Scientifics Inc
9.1M
-9.4x
-11.64%
United StatesGBLX
GB Sciences Inc
9.2M
-4.4x
---
United StatesHDVY
Health Discovery Corp
11.2M
-3.8x
---
United StatesNLSP
NLS Pharmaceutics AG
11.3M
-1.7x
---
As of 2022-01-22

Company Information

Halberd Corporation is a biotechnology company. The Company is a research-based company that intends to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is applicable for hard-to-cure blood-borne and neurologic diseases, such as post-traumatic stress disorder (PTSD) and Alzheimer's disease. It is also developing treatment for coronavirus disease of 2019 (Covid-19), obesity, such as high blood pressure, diabetes, heart disease, stroke, and cancer.

Contact Information

Headquarters
P.O. Box 25JACKSON CENTER, PA, United States 16133
Phone
---
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.0M
Revenue (TTM)
$281.2K
Shares Outstanding
511.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-7.59
EPS
$0.00
Book Value
$0.00
P/E Ratio
8.4x
Price/Sales (TTM)
35.7
Price/Cash Flow (TTM)
395.3x
Operating Margin
34.12%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.